Livforsakringsbolaget Skandia’s ResMed RMD Stock Holding History

Livforsakringsbolaget Skandia’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$252K	Hold	1,124	–	–	0.01%	294
2025 Q4	$271K	Hold	1,124	–	–	0.01%	292
2025 Q3	$308K	Sell	1,124 -100	-8%	-$27.3K	0.01%	303
2025 Q2	$315K	Hold	1,224	–	–	0.01%	314
2025 Q1	$274K	Hold	1,224	–	–	0.02%	328
2024 Q4	$280K	Hold	1,224	–	–	0.01%	330
2024 Q3	$299K	Buy	1,224 +874	+250%	+$195K	0.02%	342
2024 Q2	$67K	Hold	350	–	–	0.01%	342
2024 Q1	$69.3K	Hold	350	–	–	0.01%	360
2023 Q4	$60.2K	Buy	350 +147	+72%	+$22.6K	0.01%	369
2023 Q3	$30K	Hold	203	–	–	﹤0.01%	412
2023 Q2	$44.4K	Hold	203	–	–	﹤0.01%	349
2023 Q1	$44.4K	Hold	203	–	–	﹤0.01%	351
2022 Q4	$42.2K	Hold	203	–	–	﹤0.01%	355
2022 Q3	$44K	Sell	203 -800	-80%	-$182K	0.01%	337
2022 Q2	$210K	Sell	1,003 -200	-17%	-$42.6K	0.02%	329
2022 Q1	$292K	Hold	1,203	–	–	0.02%	374
2021 Q4	$313K	Sell	1,203 -1,100	-48%	-$285K	0.02%	388
2021 Q3	$607K	Hold	2,303	–	–	0.04%	302
2021 Q2	$568K	Hold	2,303	–	–	0.03%	330
2021 Q1	$447K	Hold	2,303	–	–	0.03%	332
2020 Q4	$490K	Buy	2,303 +1,100	+91%	+$219K	0.04%	308
2020 Q3	$206K	Sell	1,203 -600	-33%	-$111K	0.02%	382
2020 Q2	$346K	Buy	1,803 +400	+29%	+$65.4K	0.04%	285
2020 Q1	$207K	Hold	1,403	–	–	0.03%	335
2019 Q4	$217K	Sell	1,403 -500	-26%	-$72.1K	0.03%	319
2019 Q3	$257K	Hold	1,903	–	–	0.03%	354
2019 Q2	$232K	Buy	1,903 +600	+46%	+$66.5K	0.03%	364
2019 Q1	$135K	Hold	1,303	–	–	0.02%	422
2018 Q4	$148K	Hold	1,303	–	–	0.02%	369
2018 Q3	$150K	Sell	1,303 -900	-41%	-$98.6K	0.02%	436
2018 Q2	$228K	Hold	2,203	–	–	0.02%	473
2018 Q1	$217K	Hold	2,203	–	–	0.02%	480
2017 Q4	$187K	Sell	2,203 -500	-18%	-$41.3K	0.02%	502
2017 Q3	$208K	Hold	2,703	–	–	0.02%	515
2017 Q2	$210K	Hold	2,703	–	–	0.02%	507
2017 Q1	$195K	Sell	2,703 -7,300	-73%	-$504K	0.02%	518
2016 Q4	$621	Sell	10,003 -22,497	-69%	-$1.38M	0.03%	514
2016 Q3	$2.09M	Buy	32,500 +22,497	+225%	+$1.5M	0.1%	272
2016 Q2	$632K	Hold	10,003	–	–	0.03%	557
2016 Q1	$578K	Hold	10,003	–	–	0.03%	574
2015 Q4	$537K	Sell	10,003 -5,000	-33%	-$282K	0.03%	594
2015 Q3	$765K	Hold	15,003	–	–	0.04%	507
2015 Q2	$846K	Hold	15,003	–	–	0.04%	512
2015 Q1	$1.08M	Sell	15,003 -5,600	-27%	-$364K	0.05%	433
2014 Q4	$1.16M	Hold	20,603	–	–	0.05%	464
2014 Q3	$1.01M	Hold	20,603	–	–	0.04%	506
2014 Q2	$1.04M	Hold	20,603	–	–	0.04%	508
2014 Q1	$920K	Buy	+20,603	New	+$925K	0.03%	533

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Livforsakringsbolaget Skandia's RMD Position: Q1 2026 in Review

Livforsakringsbolaget Skandia held its ResMed (RMD) position steady in Q1 2026 at 1,124 shares worth $252K. The position accounts for 0.01% of the portfolio, ranked #294.

Livforsakringsbolaget Skandia first reported a position in RMD in Q1 2014 and has held it in 49 quarters since. The position peaked at $2.09M in Q3 2016. 940 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Livforsakringsbolaget Skandia held 1,124 shares of ResMed worth $252K as of Q1 2026.
Livforsakringsbolaget Skandia left its ResMed share count unchanged in Q1 2026.
ResMed made up 0.01% of Livforsakringsbolaget Skandia's portfolio in Q1 2026, its #294 holding.
Livforsakringsbolaget Skandia first reported a position in ResMed in Q1 2014 and has held it in 49 quarters since.
Livforsakringsbolaget Skandia's ResMed position peaked at $2.09M in Q3 2016.
940 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Livforsakringsbolaget Skandia's 13F filing for Q1 2026, filed 5 May 2026.